Adiponectin

There are 719 papers on adiponectin in aging research: 187 trials and 231 observational studies in people, 166 in animals, 6 in cells, 123 reviews. The newest story, Nov 18, 2026: “Low-intensity exercise improved fitness in women 85 and older”.

Biomarker

719 papers study it182 more mention it359 findings

MeSH

36 new papers in 30 daysSee all 901 papers on adiponectin

“Only subjects with GG genotype showed a significant increase of the adiponectin levels after both diets”
Single nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 interact with different type of dietary fatty acids in two hypocaloric dietsEuropean review for medical and pharmacological sciences2019doi:10.26355/eurrev_201904_17577
  • Human trial187
  • Humans231
  • Animals166
  • Cells6
  • In silico3

Interventions

101

Caloric restriction

upin mice4upin humans3upin rats3no changein humans1+1+7% weight loss

12 studies
  1. Caloric restriction increases adiponectin in humans (7% weight loss).

    “CTX-I and adiponectin concentrations were increased following 7% weight loss independently of supplement use.”

    Human trial3 monthsn = 64

    The Effect of Caloric Restriction with and without n-3 PUFA Supplementation on Bone Turnover Markers in Blood of Subjects with Abdominal Obesity: A Randomized Placebo-Controlled Trial

    Nutrients

  2. Caloric restriction increases adiponectin in humans (participants in the caloric restriction and usual activity arm, moderate to severe CKD) (+23% (95% CI 0.2% to 49.8%)).

    “Plasma adiponectin levels increased significantly in response to diet by 23% (95% CI: 0.2%, 49.8%, p = 0.048)”

    Human trialparticipants in the caloric restriction and usual activity arm, moderate to severe CKD10%-15% reduction in caloric intake

    Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  3. Caloric restriction showed no clear effect on adiponectin in humans (obesity).

    “A moderate dietary intervention did not correct adiponectin, antioxidant status, vWF, TM, and plasminogen activator inhibitor-1 (PAI-1) but ameliorated changes in other parameters.”

    Human trialobesity15 - 30% energy deficitserum8 weeksfemalesn = 41

    Weight loss-dependent and -independent effects of moderate calorie restriction on endothelial cell markers in obesity

    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

  4. Caloric restriction increases adiponectin in mice (30% CR).

    “CR also increased adiponectin, corticosterone, and ketones”

    Animals30% CR1, 2, 4, or 6 weeks

    Caloric restriction exerts site-, sex-, and duration-dependent effects on skeletal structure and bone marrow adiposity

    The Journal of endocrinology

  5. Caloric restriction increases adiponectin in aged and obese rats.

    “a major increase in circulating adiponectin levels”

    Animalsin aged and obese rats-40%6 months

    Antioxidant/Anti-Inflammatory Effects of Caloric Restriction in an Aged and Obese Rat Model: The Role of Adiponectin

    Biomedicines

  6. Caloric restriction showed no clear effect on adiponectin in mice (compared with high-fat diet group).

    “adiponectin and MCP-1 did not change.”

    Animalscompared with high-fat diet grouphigh-fat calorie-restricted dietmales

    Caloric restriction-induced weight loss with a high-fat diet does not fully recover visceral adipose tissue inflammation in previously obese C57BL/6 mice

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

  7. Caloric restriction increases adiponectin in mice.

    “RF induced significant release of adiponectin, a hormone related to glucose metabolism.”

    Animals70% of ad libitum food access

    Preconditioning with partial caloric restriction confers long-term protection against grey and white matter injury after transient focal ischemia

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

  8. Caloric restriction increases adiponectin in rats (on high-sodium diet).

    “CR in rats on a high-sodium diet improved metabolic parameters, renal transforming growth factor-β and collagen-1α1 and increased plasma adiponectin and renal visfatin and NAD+ protein levels.”

    Animalson high-sodium dietplasma60% of caloric intake4 weeks

    Combined Salt and Caloric Restrictions: Potential Adverse Outcomes

    Journal of the American Heart Association

  9. Caloric restriction increases adiponectin in mice.

    “Serum adiponectin levels were higher in CR and lower in HFD compared with the Control.”

    Animals16 wksmales

    Effects of mild calorie restriction on lipid metabolism and inflammation in liver and adipose tissue

    Biochemical and biophysical research communications

  10. Caloric restriction increases adiponectin in humans.

    “Caloric restriction, moderate alcohol consumption, and consuming a Mediterranean diet increase adiponectin concentrations”

    Review

    The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions

    The Journal of nutrition

All 12

More on Caloric restriction

Exercise

upin humans3no changein humans3upin mice1

7 studies
  1. Exercise increases adiponectin in humans (women with overweight or obesity) (SMD = 0.60).

    “Exercise raised adiponectin (SMD = 0.60; P < 0.05)”

    Human trialwomen with overweight or obesityfemalesn = 1,987

    Divergent responses of adiponectin and leptin to exercise in women with overweight or obesity: a systematic review and meta-regression

    Frontiers in physiology

  2. Exercise showed no clear effect on adiponectin in humans (overweight and obese postmenopausal women).

    “Changes in IL-6 and adiponectin were not statistically significant.”

    Human trialoverweight and obese postmenopausal womenfemalesn = 2,124

    Effects of exercise intensity and volume on systemic inflammation in overweight and obese postmenopausal women: a dose-response meta-analysis

    Frontiers in immunology

  3. Exercise showed no clear effect on adiponectin in humans (MD 0.15 μg/mL (95% CI -0.43 to 0.72, p = 0.61)).

    “No significant changes in adiponectin levels were observed (MD = 0.15 μg/mL, 95% CI: -0.43 to 0.72, p = 0.61).”

    Human trialn = 1,130

    Effect of exercise on abdominal obesity and inflammatory response in the older adults: a systematic review and meta-analysis of randomized controlled trials

    Frontiers in sports and active living

  4. Exercise was not clearly linked with adiponectin in humans (OGTT; no difference by age or activity status).

    “Adiponectin concentration during the OGTT did not differ by age (P = 0.448) or activity status (P = 0.611).”

    HumansOGTT; no difference by age or activity status

    Fibroblast Growth Factor 21 Mediates the Associations between Exercise, Aging, and Glucose Regulation

    Medicine and science in sports and exercise

  5. Exercise increases adiponectin in mice.

    “PA significantly increased adiponectin levels in the ovary”

    Animalsovary

    Physical activity delayed ovarian aging in mice

    Nature aging

  6. Exercise increases adiponectin in overweight and obese individuals.

    “Nearly all interventions reduced leptin levels and increased adiponectin levels.”

    Reviewin overweight and obese individuals

    Effects of exercise alone or combined with dietary restriction on leptin and adiponectin in overweight or obese individuals: a network meta-analysis

    BMC sports science, medicine & rehabilitation

  7. Exercise increases adiponectin in humans (overweight and obesity) (MD: 0.33, 95 % CI: 0.02 to 0.65, p = 0.04).

    “exercise can significantly increase the level of adiponectin (MD: 0.33, 95 % CI: 0.02 to 0.65, p = 0.04)”

    Reviewoverweight and obesityeight weeksfemales

    Effect of exercise on inflammatory markers in postmenopausal women with overweight and obesity: A systematic review and meta-analysis

    Experimental gerontology

More on Exercise

Testosterone

downin humans6

6 studies
  1. Testosterone decreases adiponectin in humans (added to lifestyle therapy) (−408 ± 489 ng/mL vs 1832 ± 468 ng/mL).

    “On the other hand, although adiponectin levels increased in the LT + Pbo group (1832 ± 468 ng/mL [16% change from baseline]), no significant change was observed in the LT + TRT group (−408 ± 489 ng/mL [4% change]).”

    Human trialadded to lifestyle therapy26 weeksmalesn = 83

    Metabolic Effects of Testosterone Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism

    The Journal of clinical endocrinology and metabolism

  2. Testosterone decreases adiponectin in humans (older men with obesity and hypogonadism receiving lifestyle therapy) (-408 ± 489 ng/mL vs 1832 ± 468 ng/mL, P = .02).

    “and adiponectin levels (-408 ± 489 ng/mL in LT + TRT group vs 1832 ± 468 ng/mL in LT + Pbo group, P = .02).”

    Human trialolder men with obesity and hypogonadism receiving lifestyle therapy6 monthsmalesn = 83

    Metabolic Effects of Testosterone Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism

    The Journal of clinical endocrinology and metabolism

  3. Testosterone decreases adiponectin in humans (type 2 diabetes mellitus).

    “TRT has an ambiguous impact on the adipokine profile with a potential harmful decrease in levels of adiponectin”

    Human trialtype 2 diabetes mellitusmales

    Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study

    Danish medical journal

  4. Testosterone decreases adiponectin in humans (type 2 diabetes mellitus and bioavailable testosterone <7.3 nmol/L) (b = -0.4 mg/L, P = 0.045).

    “levels of adiponectin (b = -0.4 mg/L, P = 0.045)”

    Human trialtype 2 diabetes mellitus and bioavailable testosterone <7.3 nmol/L24 weeksmalesn = 39

    MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial

    European journal of endocrinology

  5. Testosterone decreases adiponectin in humans (non-diabetic men with low testosterone) (-1.8 ± 0.9 mg/L).

    “Adiponectin levels significantly decreased in the TT group (-1.8 ± 0.9 mg/L, p = 0.02)”

    Human trialnon-diabetic men with low testosteronetransdermal gel5 g daily12 monthsmalesn = 10

    Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters

    Andrology

  6. Testosterone decreases adiponectin in humans (b = -1.3 mg/l, P = 0.001).

    “Adiponectin levels decreased during testosterone therapy (b = -1.3 mg/l, P = 0.001).”

    Human trialgel6 monthsmalesn = 38

    Testosterone therapy decreases subcutaneous fat and adiponectin in aging men

    European journal of endocrinology

  7. Testosterone decreases adiponectin in hypogonadal type 2 diabetic men (-2075.8 +/- 852.3 ng/ml, P=0.02).

    “and adiponectin levels (-2075.8 +/- 852.3 ng/ml; P=0.02).”

    Human trialin hypogonadal type 2 diabetic mensustanon200 mg every 2 weeks3 monthsmalesn = 20

    The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes

    European journal of endocrinology

More on Testosterone

Curcumin

upin humans5

5 studies
  1. Curcumin increases adiponectin in patients with metabolic syndrome (P < 0.001).

    “Eight-week supplementation with curcumin was associated with a significant increase in serum adiponectin levels (P < 0.001)”

    Human trialin patients with metabolic syndromeserum1000 mg/d8 wk

    Effects of supplementation with curcumin on serum adipokine concentrations: A randomized controlled trial

    Nutrition (Burbank, Los Angeles County, Calif.)

  2. Curcumin increases adiponectin in humans.

    “Levels of adiponectin, an anti-inflammatory cytokine, in the placebo-treated group were virtually unchanged, whereas those of the curcumin-treated group were gradually elevated (at 3 and 6 months) and became significantly different from that of placebo-treated group at the final visit (9 months).”

    Human trial9 monthsn = 237

    Curcumin extract for prevention of type 2 diabetes

    Diabetes care

  3. Curcumin increases adiponectin in humans (22.46 vs. 18.45 (P < 0.05)).

    “higher adiponectin (22.46 vs. 18.45; P < 0.05) when compared with the placebo group.”

    Human trial9 monthsn = 240

    Curcumin extract for prevention of type 2 diabetes

    Diabetes care

  4. Curcumin increases adiponectin in humans (SMD = 0.86, 95% CI (0.33, 1.39)).

    “Curcumin supplementation was effective in increasing serum adiponectin (SMD = 0·86, 95 % CI (0·33, 1·39), P < 0·001”

    Reviewserum

    The effect of curcumin supplementation on circulating adiponectin and leptin concentration in adults: a GRADE-assessed systematic review and meta-analysis of randomised controlled trials

    The British journal of nutrition

  5. Curcumin increases adiponectin in humans (adults) (WMD = 2.48 μg/mL; 95% CI: 1.34, 3.62, p < 0.001).

    “increased adiponectin (WMD = 2.48 μg/mL; 95% CI: 1.34, 3.62, p < 0.001)”

    Reviewadults

    Effects of curcumin/turmeric supplementation on obesity indices and adipokines in adults: A grade-assessed systematic review and dose-response meta-analysis of randomized controlled trials

    Phytotherapy research : PTR

  6. Curcumin increases adiponectin in humans (WMD: 0.82 Hedges' g; 95% CI: 0.33 to 1.30, P˂0.001).

    “curcumin supplementation significantly increased adiponectin concentrations in comparison with placebo (WMD: 0.82 Hedges' g; 95% confidence interval (CI): 0.33 to 1.30, P˂0.001)”

    Reviewn = 652

    The effect of curcumin supplementation on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials

    Diabetes & metabolic syndrome

More on Curcumin

Resveratrol

upin humans2upin F. catus1no changein humans1upin pigs1

5 studies
  1. Resveratrol showed no clear effect on adiponectin in humans (patients with nonalcoholic fatty liver disease).

    “No significant differences were observed in the serum levels of PAI-1, adiponectin, FGF-21, and hs-CRP between the two groups at the end of the study.”

    Human trialpatients with nonalcoholic fatty liver diseasecapsule12 weeksn = 50

    Effects of resveratrol supplementation on serum concentrations of plasminogen activator inhibitor-1, fibroblast growth factor 21, and adiponectin in patients with nonalcoholic fatty liver disease

    BMC nutrition

  2. Resveratrol increases adiponectin in humans (change within resveratrol group) (1.22 ng/mL (-0.37, 1.60)).

    “elevation of adiponectin level [1.22 (-0.37, 1.60) ng/mL, P=0.025] were observed”

    Human trialchange within resveratrol group150 mg capsules2 capsules of 150 mg twice dailythree monthsn = 60

    Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

  3. Resveratrol increases adiponectin in obese and overweight cats.

    “adiponectin concentrations increased markedly in obese and overweight cats after RSV supplementation.”

    Animalsin obese and overweight cats4 weeks

    Effect of resveratrol supplementation on lipid metabolism in healthy and obese cats

    Frontiers in veterinary science

  4. Resveratrol increases adiponectin in pigs.

    “greater dramatically the serum concentration of adiponectin and high-density lipoprotein in pigs”

    Animals400 mg/kg and 600 mg/kg41 d

    Resveratrol inhibits the formation and accumulation of lipid droplets through AdipoQ signal pathway and lipid metabolism lncRNAs

    The Journal of nutritional biochemistry

  5. Resveratrol increases adiponectin in humans (WMD: 1.10 μg/ml, 95% CI: 0.88, 1.33, p<0.001).

    “Meta-analysis of data from 10 treatment arms showed a significant change in plasma adiponectin concentrations following resveratrol supplementation (WMD: 1.10μg/ml, 95%CI: 0.88, 1.33, p<0.001)”

    Review≥100 mg/day

    Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials

    Pharmacological research

More on Resveratrol

Melatonin

upin humans2upin mice1no changein reviews1

4 studies
  1. Melatonin increases adiponectin in obese patients on a calorie-restricted diet.

    “Thirty days of melatonin supplementation resulted in the significant increases in the serum adiponectin and omentin-1 concentrations, as well as the erythrocytic GPx activities.”

    Human trialin obese patients on a calorie-restricted diet30 days

    Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet

    Oxidative medicine and cellular longevity

  2. Melatonin increases adiponectin in humans (+21% (P = 0.08)).

    “Adiponectin increased borderline significantly by 21% in the melatonin group compared to placebo (P = 0·08).”

    Human trial1 or 3 mg nightly1 yearfemalesn = 81

    Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial

    Clinical endocrinology

  3. Melatonin showed no clear effect on adiponectin (WMD 1.432 μg/mL; 95% CI −0.112 to 2.976).

    “melatonin supplementation does not significantly affect serum leptin and adiponectin levels.”

    Review

    Impact of melatonin supplementation on plasma leptin and adiponectin levels: systematic review and GRADE-assessed meta-analysis of randomized controlled trials

    Clinical nutrition research

  4. Melatonin increases adiponectin in mice (SAMP8 mice).

    “Decreased expression of adiponectin and adiponectin receptor 1 was also observed in visceral fat of untreated SAMP8, whereas a significant increase was observed after melatonin treatment.”

    AnimalsSAMP8 micevisceral adipose tissue10 monthsn = 7

    Effect of long-term treatment with melatonin on vascular markers of oxidative stress/inflammation and on the anticontractile activity of perivascular fat in aging mice

    Hypertension research : official journal of the Japanese Society of Hypertension

More on Melatonin

Resistance training

upin humans2downin humans2

4 studies
  1. Resistance training increases adiponectin in humans.

    “Adiponectin increased significantly in both exercise groups, with the largest increase in REG.”

    Human triallow-intensity24 weeksfemales

    Low-intensity exercise improved fitness in women 85 and older

    European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity

  2. Resistance training decreases adiponectin in resistance-trained young men (p < 0.001).

    “Plasma adiponectin significantly decreased from baseline to 48 h post-exercise in both sessions (p < 0.001)”

    Human trialin resistance-trained young menmalesn = 9

    Acute Resistance Exercise Temporarily Reduces Circulating Adiponectin in Trained Young Men: A Pilot Study

    Biomolecules

  3. Resistance training decreases adiponectin in humans (both leucine and placebo groups during 10-week resistance training) (LEU 652 ± 513 to 292 ± 447 pg/ml; PLC 584 ± 572 to 245 ± 356 pg/ml; p = 0.002).

    “There were significant decreases in adiponectin concentrations in both groups”

    Human trialboth leucine and placebo groups during 10-week resistance training10 weeksfemalesn = 35

    Effects of L-Leucine Supplementation and Resistance Training on Adipokine Markers in Untrained Perimenopausal and Postmenopausal Women

    Journal of strength and conditioning research

  4. Resistance training increases adiponectin in humans (Premenopausal and postmenopausal women with obesity).

    “Adiponectin concentrations were significantly increased after resistance exercise in both groups.”

    Human trialPremenopausal and postmenopausal women with obesity12 weeksfemalesn = 23

    Effect of Resistance Exercise on the Lipolysis Pathway in Obese Pre- and Postmenopausal Women

    Journal of personalized medicine

More on Resistance training

High-intensity interval training

no changein humans1downin humans1upin humans1

3 studies
  1. High-intensity interval training decreases adiponectin in humans.

    “Analysis of the changes in adiponectin concentration induced by 8-week HIIT showed a significant interaction of time and term (p < 0.05).”

    Human trialeight weeksmalesn = 41

    Ashwagandha Does Not Enhance the Effect of High-Intensity Interval Training on Selected Energy Metabolism Parameters in Young Healthy Men

    Nutrients

  2. High-intensity interval training decreases adiponectin in humans (p < 0.05).

    “the 8-week HIIT decreased resting levels of adiponectin and increased irisin levels post-exercise and after 24 h (p < 0.05).”

    Human trial8 weeksmales

    Ashwagandha Does Not Enhance the Effect of High-Intensity Interval Training on Selected Energy Metabolism Parameters in Young Healthy Men

    Nutrients

  3. High-intensity interval training increases adiponectin in humans after 4 weeks of detraining (1.78-fold vs control).

    “However, after four weeks of detraining, the adiponectin concentration remained 1.78-fold in the L-HIIT group than in the control group (p=0.033, ES=0.157).”

    Human trialafter 4 weeks of detraining8 weeks

    Effects of different HIIT protocols on exercise performance, metabolic adaptation, and fat loss in middle-aged and older adults with overweight

    International journal of medical sciences

  4. High-intensity interval training increases adiponectin in humans (overweight) (1.78 times higher).

    “following a four-week detraining stage, the adiponectin concentration remained 1.78 times higher in the L-HIIT group than in the control group (p=0.033).”

    Human trialoverweight4 × 4 min Exercise/4 min Rest4 weeks detraining

    Effects of different HIIT protocols on exercise performance, metabolic adaptation, and fat loss in middle-aged and older adults with overweight

    International journal of medical sciences

  5. High-intensity interval training showed no clear effect on adiponectin in overweight and obese individuals.

    “HIIT training generally did not affect adiponectin levels in overweight and obese individuals.”

    Reviewin overweight and obese individuals

    Adiponectin response to high-intensity interval training in overweight and obese individuals: a systematic review and meta-analysis

    British medical bulletin

More on High-intensity interval training

Cholecalciferol

upin humans3

3 studies
  1. Cholecalciferol increases adiponectin in adult epilepsy patients treated with enzymatic antiseizure medications (1.38 ± 3.05 vs. 0.34 ± 1.89 μg/mL).

    “Vitamin D supplementation yielded a significantly greater increase in serum 25(OH)D (10.67 ± 8.16 vs. –1.29 ± 3.96 ng/mL; p < 0.001) and adiponectin (1.38 ± 3.05 vs. 0.34 ± 1.89 μg/mL; p = 0.045)”

    Human trialin adult epilepsy patients treated with enzymatic antiseizure medications2,000 IU/day12 weeks

    Effect of vitamin D supplementation on metabolic syndrome and atherosclerosis biomarkers in epilepsy: a randomized controlled trial

    Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina

  2. Cholecalciferol increases adiponectin in humans (postmenopausal women) (+18.6% (11.5 ± 5.5 vs 18.5 ± 21.8 ng/mL, P = 0.047 at end point)).

    “In the vitamin D group, there was an increase in adiponectin (+18.6%)”

    Human trialpostmenopausal womenoralserum1,000 IU/d9 monthsfemalesn = 80

    Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial

    Menopause (New York, N.Y.)

  3. Cholecalciferol increases adiponectin in humans (adjusted for baseline values, season, sun exposure, and dietary vitamin D intake) (β[95%CI] = 13.7[2.0, 25.5], p = 0.02).

    “there was a greater increase in adiponectin (β[95%CI] = 13.7[2.0, 25.5], p = 0.02) and leptin (β[95%CI] = 22.3[3.8, 40.9], p = 0.02) in the vitamin D group compared with placebo”

    Human trialadjusted for baseline values, season, sun exposure, and dietary vitamin D intake16 weeks

    Vitamin D supplementation increases adipokine concentrations in overweight or obese adults

    European journal of nutrition

More on Cholecalciferol

Acarbose

upin humans2no changein humans1

3 studies
  1. Acarbose increases adiponectin in humans (WMD 0.79 ng/ml (95% CI 0.02 to 1.55)).

    “while increasing adiponectin (WMD = 0.79 ng/ml, 95% CI 0.02, 1.55; P = 0.044)”

    Human trial

    The effect of acarbose on inflammatory cytokines and adipokines in adults: a systematic review and meta-analysis of randomized clinical trials

    Inflammopharmacology

  2. Acarbose showed no clear effect on adiponectin in humans.

    “but not fasting adiponectin levels were significantly lower during acarbose versus placebo treatment.”

    Human trial100 mg three times daily12 weeksn = 66

    Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation

    Diabetes technology & therapeutics

  3. Acarbose increases adiponectin in patients with type 2 diabetes.

    “acarbose therapy led to a significant increase of adiponectin after 3 months of administration compared with baseline”

    Human trialin patients with type 2 diabetes300 mg/day3 months

    Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients

    Journal of thrombosis and thrombolysis

More on Acarbose

Omega-3 fatty acids

upin humans3

3 studies
  1. Omega-3 fatty acids increase adiponectin in humans.

    “Analysis of variance revealed a significant effect of ω-3 PUFA supplementation on serum adiponectin concentration (F = 22.7; p < 0.001).”

    Human trialthree weeksmalesn = 24

    The Effect of Omega-3 Fatty Acid Supplementation on Serum Adipocytokines, Lipid Profile and Biochemical Markers of Inflammation in Recreational Runners

    Nutrients

  2. Omega-3 fatty acids increase adiponectin in humans (prediabetes or type 2 diabetes; effect not robust in sensitivity analysis) (0.48 μg/mL; 95% CI 0.27 to 0.68).

    “Omega-3 supplementation increased levels of adiponectin (0.48 μg/mL; 95% confidence interval [CI], 0.27 to 0.68; P<0.00001, n=10 trials)”

    Reviewprediabetes or type 2 diabetes; effect not robust in sensitivity analysisn = 685

    Effects of Omega-3 Supplementation on Adipocytokines in Prediabetes and Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Diabetes & metabolism journal

  3. Omega-3 fatty acids increase adiponectin in humans.

    “current evidence suggests a positive, dose-dependent relation between ω-3 (n-3) fatty acid intake and circulating concentrations of adiponectin”

    Review

    The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions

    The Journal of nutrition

More on Omega-3 fatty acids

Coenzyme Q10

upin humans2no changein humans1

3 studies
  1. Coenzyme Q10 increases adiponectin in women with T2DM.

    “Serum values of adiponectin (p = .001) and the A/L ratio (p = .001) were increased”

    Human trialin women with T2DMserum100 mg per day12 weeksfemalesn = 34

    Effects of coenzyme Q10 supplementation on serum values of adiponectin, leptin, 8-isoprostane and malondialdehyde in women with type 2 diabetes

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

  2. Coenzyme Q10 increases adiponectin in humans (compared with placebo) (adiponectin 21.1 ± 14.5 to 24.2 ± 15.5 ng/ml; between-group P = 0.04).

    “The mean enhancement in adiponectin of QG was significantly higher than PG (from 21.1 ± 14.5 to 24.2 ± 15.5 ng/ml, P = 0.04).”

    Human trialcompared with placebocapsule100 mg per day12 weeksn = 60

    The Effect of Coenzyme Q10 Supplementation on Pro-Inflammatory Factors and Adiponectin in Mildly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition

  3. Coenzyme Q10 showed no clear effect on adiponectin in humans.

    “Both CoQ10 and placebo supplementation did not affect plasma adiponectin and TNF-alpha levels.”

    Human trialoralplasma100 mg/day8 weeksmalesn = 14

    Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor-alpha levels in men

    Journal of medicinal food

More on Coenzyme Q10

Exenatide

upin mouse cells2upin humans1

3 studies
  1. Exenatide increases adiponectin in humans (compared with acarbose at 3 months) (P=0.025 versus control group).

    “Adiponectin level was higher in the GLP-1 group than the control group at 3 months (P=0.025).”

    Human trialcompared with acarbose at 3 months3 months

    Comparison of exenatide and acarbose on intra-abdominal fat content in patients with obesity and type-2 diabetes: A randomized controlled trial

    Obesity research & clinical practice

  2. Exenatide increases adiponectin in stressed mice.

    “Exenatide also stimulated APN expression of preadipocytes”

    Cellsin stressed micepreadipocytes

    Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress

    Atherosclerosis

  3. Exenatide increases adiponectin in 3T3-L1 cells.

    “the GLP-1 receptor agonist exenatide stimulated APN expression in 3T3-L1 cells.”

    Cellsin 3T3-L1 cells

    Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress

    International journal of cardiology

More on Exenatide

Fish oil

upin humans3+22%

3 studies
  1. Fish oil increases adiponectin in humans with at least one cardiovascular risk factor.

    “After supplementation, the ω-3 group showed an increase in serum adiponectin.”

    Human trialwith at least one cardiovascular risk factorserum3 g/d2-mon = 80

    The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial

    Nutrition (Burbank, Los Angeles County, Calif.)

  2. Fish oil increases adiponectin in humans (+45 TT genotype) (+22%).

    “Individuals homozygous for the +45 T-allele aged >58 y had a 22% increase in serum adiponectin concentration compared with baseline after the highest dose (P-treatment effect = 0.008).”

    Human trial+45 TT genotype1.8 g/d12 mo

    Adiponectin gene variant interacts with fish oil supplementation to influence serum adiponectin in older individuals

    The Journal of nutrition

  3. Fish oil increases adiponectin in humans (overweight subjects) (+0.55 μg/mL (95% CI 0.02–1.08)).

    “Serum adiponectin levels were increased by 0.55 μg/mL (95% confidence interval, 0.02-1.08) in the fish oil group compared with the control group (P = .04) after 6 weeks of supplementation.”

    Human trialoverweight subjectsserum2 g/day (1.1 g marine n-3 PUFA)6 weeksn = 50

    Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects

    Nutrition research (New York, N.Y.)

More on Fish oil

Aerobic exercise

upin humans2

2 studies
  1. Aerobic exercise increases adiponectin in humans.

    “Moreover, the increase in serum adiponectin, CTRP3, and CTRP5 from baseline to 8 wk was significantly higher in the training group compared with the control group”

    Human trialserum8 wkn = 52

    Aerobic exercise training-induced changes in serum C1q/TNF-related protein levels are associated with reduced arterial stiffness in middle-aged and older adults

    American journal of physiology. Regulatory, integrative and comparative physiology

  2. Aerobic exercise increases adiponectin in type 2 diabetes mellitus patients with overweight or obesity (SMD = 1.13, 95% CI: 0.42, 1.84, P = 0.002).

    “as well as increasing adiponectin (SUCRA = 76.7; SMD = 1.13; 95% CI: 0.42, 1.84; P = 0.002) levels.”

    Reviewin type 2 diabetes mellitus patients with overweight or obesity

    Comparative effects of different exercise types on inflammatory markers in type 2 diabetes mellitus patients with overweight and obesity: a systematic review and network meta-analysis

    BMC endocrine disorders

More on Aerobic exercise

All 101

Effects

20

Type 2 diabetes

mediatesin humans1no changein humans1downin reviews1

2 studies
  1. Adiponectin is linked with type 2 diabetes in humans (potential mediation of the relationship between visceral fat and type 2 diabetes).

    “Two-Step network MR showed that adiponectin could mediate the relationship between visceral fat and T2D in women.”

    Humanspotential mediation of the relationship between visceral fat and type 2 diabetesfemales

    Genetic study finds no clear hormone effect on type 2 diabetes

    Canadian journal of diabetes

  2. Adiponectin was not clearly linked with type 2 diabetes in humans (Mendelian randomization accounting for adiposity-related traits).

    “our MR results did not show a causal association between adiponectin levels and T2D.”

    HumansMendelian randomization accounting for adiposity-related traits

    Genetic study finds no clear hormone effect on type 2 diabetes

    Canadian journal of diabetes

  3. Adiponectin protects against type 2 diabetes.

    “Adiponectin is a fat-derived hormone whose reduction plays central roles in obesity-linked diseases including insulin resistance/type 2 diabetes and atherosclerosis.”

    Review

    Adiponectin receptor as a key player in healthy longevity and obesity-related diseases

    Cell metabolism

More on Type 2 diabetes

Fasting glucose

mediatesin humans1

1 study
  1. Adiponectin is linked with fasting glucose in humans (potential mediation of the relationship between adiposity and fasting glucose).

    “ALSPAC results suggest that adiponectin may mediate the relationship between adiposity and fasting glucose levels in youth.”

    Humanspotential mediation of the relationship between adiposity and fasting glucose

    Genetic study finds no clear hormone effect on type 2 diabetes

    Canadian journal of diabetes

More on Fasting glucose

Physical function

downin humans1OR 2.11

1 study
  1. Adiponectin is linked with worse physical function in humans (older adults with CKM syndrome) (OR = 2.11, 95% CI: 1.52-2.98).

    “higher adiponectin was independently associated with higher odds of low physical function (OR = 2.11, 95% CI: 1.52-2.98)”

    Humansolder adults with CKM syndrome

    Associations of adiponectin, leptin, and the adiponectin-to-leptin ratio with sarcopenia in older adults with cardiovascular-kidney-metabolic syndrome

    The journal of nutrition, health & aging

Perioperative neurocognitive disorder

downin humans1HR 0.307

1 study
  1. Adiponectin is linked with less perioperative neurocognitive disorder in humans (elderly patients undergoing thoracic surgery) (HR 0.307, 95% CI 0.113-0.835, p = 0.021).

    “High serum APN, AQP4, and BDNF levels were independent protective factors for PND”

    Humanselderly patients undergoing thoracic surgeryserum

    Risk Assessment of Serum Biomarkers with Perioperative Neurocognitive Dysfunction in Elderly Patients Undergoing Thoracic Surgery: A Prospective Cohort Study

    Cellular and molecular neurobiology

More on Perioperative neurocognitive disorder

Oxidative stress and ROS signaling

downin reviews1

1 study
  1. Adiponectin decreases oxidative stress and ROS signaling.

    “Conversely, adiponectin enhances insulin sensitivity, suppresses oxidative stress, and supports mitochondrial and endothelial function”

    Review

    Adipokines at the Metabolic-Brain Interface: Therapeutic Modulation by Antidiabetic Agents and Natural Compounds in Alzheimer's Disease

    Pharmaceuticals (Basel, Switzerland)

More on Oxidative stress and ROS signaling

Sarcopenia

no changein humans1

1 study
  1. Adiponectin was not clearly linked with sarcopenia in humans (non-geriatric type 2 diabetes mellitus) (p=0.799).

    “adiponectin levels (p=0.799) did not show statistical differences”

    Humansnon-geriatric type 2 diabetes mellitusn = 97

    Association Between Leptin and Adiponectin Levels and Sarcopenia in Non-Geriatric Type 2 Diabetes Mellitus Patients

    Acta medica Indonesiana

More on Sarcopenia

Hospitalization for infection

no changein humans1HR 1.01

1 study
  1. Adiponectin was not clearly linked with hospitalization for infection in humans (CKD patients undergoing hemodialysis) (HR 1.01 (95% CI 0.74-1.39)).

    “higher ADPN levels were not associated with hospitalization for infection (HR 1.01 [0.74-1.39])”

    HumansCKD patients undergoing hemodialysis5-year follow-upn = 518

    Higher Serum Adiponectin Levels Predict Poorer Outcomes in Patients Undergoing Hemodialysis

    ADA Scientific Sessions 2025 abstract

More on Hospitalization for infection

Insulin resistance

no changein humans1

1 study
  1. Adiponectin was not clearly linked with insulin resistance in adult patients with SMA type 3.

    “However, this correlation was not observed in patients with SMA type 3.”

    Humansin adult patients with SMA type 3n = 23

    Adiponectin and Leptin-Considerations in Adult Patients with Spinal Muscular Atrophy Type 3

    Diagnostics (Basel, Switzerland)

More on Insulin resistance

Heart failure with preserved ejection fraction

no changein humans1

1 study
  1. Adiponectin was not clearly linked with heart failure with preserved ejection fraction in humans after adjusting for NT-proBNP.

    “There was no significant association between adiponectin and heart failure with preserved ejection fraction after adjusting for NT-proBNP.”

    Humansafter adjusting for NT-proBNP

    Does Adiponectin Inform Cardiovascular Risk in Older Adults?: The ARIC Study

    JACC. Advances

More on Heart failure with preserved ejection fraction

Vasodilation

upin mice1

1 study
  1. Adiponectin improves vasodilation in SM22alpha-Cre Ercc1 knockout mice with lipodystrophy.

    “Despite strong lipodystrophy the PVAT partially compensated for lost vasodilation in SMC-KO.”

    Animalsin SM22alpha-Cre Ercc1 knockout mice with lipodystrophyperivascular adipose tissue

    Adiponectin secretion by perivascular adipose tissue supports impaired vasodilation in a mouse model of accelerated vascular smooth muscle cell and adipose tissue aging

    Vascular pharmacology

All 20

Upstream

15

Mild cognitive impairment

downin humans2

2 studies
  1. Mild cognitive impairment is linked with lower adiponectin in humans (healthcare-seeking) (1.36 vs. 2.50, p = 0.003).

    “Adiponectin was significantly lower in patients with MCI (1.36 vs. 2.50, p = 0.003)”

    Humanshealthcare-seekingn = 163

    Study of Leptin and Adiponectin among Indian Older Adults with Mild Cognitive Impairment: Initial Experience of Memory Clinic from a Geriatric Tertiary Care Center in India

    Dementia and geriatric cognitive disorders

  2. Mild cognitive impairment is linked with lower adiponectin in humans (elderly diabetic patients with MCI and depressive symptoms).

    “patients with MCI and depressive symptoms demonstrated lower adiponectin levels and high hs-CRP and TNF-α”

    Humanselderly diabetic patients with MCI and depressive symptomsserumn = 178

    Adiponectin and Inflammatory Marker Levels in the Elderly Patients with Diabetes, Mild Cognitive Impairment and Depressive Symptoms

    International journal of molecular sciences

More on Mild cognitive impairment

Vitamin D

no changein humans1

1 study
  1. Vitamin D was not clearly linked with adiponectin in humans (obese pre- and early postmenopausal women) (r = -0.008 (premenopausal), r = -0.135 (postmenopausal)).

    “There was no significant correlation between serum adiponectin and 25(OH)D in either group (r = -0.008, P = 0.949 in the premenopausal group; r = -0.135, P = 0.312 in the postmenopausal group).”

    Humansobese pre- and early postmenopausal womenserumfemalesn = 118

    Association between Serum Adiponectin and Vitamin D in Obese Pre- and Early Postmenopausal Women: A Cross-Sectional Study

    Journal of menopausal medicine

More on Vitamin D

Type 2 diabetes

downin humans1

1 study
  1. Type 2 diabetes is linked with lower adiponectin in humans (newly diagnosed T2DM compared with PreDM) (22.05 vs. 30.30 and 25.72 vs. 38.84, p < 0.0001).

    “Both adiponectin and omentin levels were lower in T2DM compared with PreDM (22.05 vs. 30.30 and 25.72 vs. 38.84, p < 0.0001 for both).”

    Humansnewly diagnosed T2DM compared with PreDM

    Circulating Adiponectin and Omentin Across Cardiometabolic Phenotypes: Links to Atherogenic Indices in Prediabetes and New-Onset Type 2 Diabetes

    International journal of molecular sciences

More on Type 2 diabetes

KIDMUTATION

upin mice1

1 study
  1. KIDMUTATION increases adiponectin in mice (variable across mice).

    “At 4 months, these mice variably display hormonal markers that associate with successful aging counteraction, including elevated adiponectin and FGF21”

    Animalsvariable across mice

    Mutation in IR or IGF1R produces features of long-lived mice while maintaining metabolic health

    JCI insight

More on KIDMUTATION

Senile osteoporosis

no changein humans1

1 study
  1. Senile osteoporosis showed no clear effect on adiponectin in humans (compared with healthy older individuals with normal bone mineral density) (MD -0.55, 95% CI: -2.26 to 1.17, P = 0.53).

    “adiponectin levels were not significantly different (MD, -0.55, 95% CI: -2.26 to 1.17, P = 0.53, I2 = 98%)”

    Reviewcompared with healthy older individuals with normal bone mineral densityserum

    The association between serum adipokines levels with senile osteoporosis: a systematic review and meta-analysis

    Frontiers in endocrinology

More on Senile osteoporosis

Obesity status

no changein humans1

1 study
  1. Obesity status was not clearly linked with adiponectin in humans (Comparison across normal weight, overweight, and obesity groups).

    “circulating adiponectin levels were not statistically different among the three groups”

    HumansComparison across normal weight, overweight, and obesity groupsfemalesn = 141

    Relationship between Adipose Tissue Derived Hormones and Cardiometabolic Risk according to Obesity Status

    Clinical nutrition research

Cryptorchidism

upin dogs1

1 study
  1. Cryptorchidism increases adiponectin in dogs (expression in pathological testes (cryptorchid and germ cell tumor)).

    “Increased expression of adiponectin and adiponectin receptor 1, as well as extracellular signal-activated kinase (ERK1/2) in pathological testes were detected.”

    Animalsexpression in pathological testes (cryptorchid and germ cell tumor)testismales

    Senescence and adiponectin signaling - Studies in canine testis

    Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft

More on Cryptorchidism

Age

downin rats1

1 study
  1. Age decreases adiponectin in rats (ad libitum-fed rats).

    “Adiponectin decreased at old age in AL rats, while no changes were evident in CR rats across age groups.”

    Animalsad libitum-fed ratsmalesn = 36

    Effects of aging and life-long moderate calorie restriction on IL-15 signaling in the rat white adipose tissue

    European review for medical and pharmacological sciences

Sarcopenia

upin humans1

1 study
  1. Sarcopenia is linked with higher adiponectin in humans (compared with non-sarcopenic overfat elderly) (p = 0.019).

    “sarcopenic individuals showed greater adiponectin concentration (p = 0.019)”

    Humanscompared with non-sarcopenic overfat elderly

    Influence of skeletal muscle mass and fat mass on the metabolic and inflammatory profile in sarcopenic and non-sarcopenic overfat elderly

    Aging clinical and experimental research

More on Sarcopenia

IL 10tm mice

downin mice1

1 study
  1. IL 10tm mice decreases adiponectin in mice (IL 10tm mice compared with age- and sex-matched C57Bl/6 mice).

    “plasma adiponectin and leptin were also decreased in IL 10tm.”

    AnimalsIL 10tm mice compared with age- and sex-matched C57Bl/6 miceplasmafemales

    Aged interleukin-10tm1Cgn chronically inflamed mice have substantially reduced fat mass, metabolic rate, and adipokines

    PloS one

More on IL 10tm mice

All 15

Associations

121

Sarcopenia

upin humans4downin humans2OR 1.264

6 studies
  1. Adiponectin predicts sarcopenia in humans (AUROC = 0.76).

    “showed the best discrimination (AUROC = 0.76)”

    Humans

    Diagnostic Performance of Serum Adiponectin and a Biomarker-Based Model for Sarcopenia in Compensated Cirrhosis

    Journal of clinical and experimental hepatology

  2. Adiponectin is associated with sarcopenia in humans (9.3 ± 3.9 vs 5.8 ± 4.0 μg/mL).

    “Serum adiponectin was significantly higher in sarcopenic patients (9.3 ± 3.9 vs 5.8 ± 4.0 μg/mL; P < 0.001)”

    Humans

    Diagnostic Performance of Serum Adiponectin and a Biomarker-Based Model for Sarcopenia in Compensated Cirrhosis

    Journal of clinical and experimental hepatology

  3. Sarcopenia is associated with adiponectin in patients with metabolic syndrome.

    “The sarcopenic subgroup had lower brachial circumference and plasma adiponectin.”

    Humansin patients with metabolic syndromen = 74

    Association of Sarcopenia with Lower Adiponectin Levels and Reduced Estimated Appendicular Lean Mass in Patients with Metabolic Syndrome: A Cross-Sectional Study

    Diseases (Basel, Switzerland)

  4. Sarcopenia is associated with adiponectin in humans (elderly diabetic patients) (12.8 ± 3.4 vs. 8.4 ± 2.1 μg/mL, +52%).

    “Sarcopenic patients demonstrated significantly higher adiponectin levels (12.8 ± 3.4 vs. 8.4 ± 2.1 μg/mL, p<0.001), representing a 52% increase compared to non-sarcopenic individuals.”

    Humanselderly diabetic patientsserumn = 80

    Association of adiponectin and nutritional indices with sarcopenia in elderly diabetic patients

    Journal of basic and clinical physiology and pharmacology

  5. Adiponectin predicts sarcopenia in humans (elderly diabetic patients) (OR 1.264, 95% CI 1.062-1.504).

    “Multiple logistic regression identified adiponectin (OR=1.264, 95% CI: 1.062-1.504, p=0.009), age, insulin resistance, and nutritional indices as independent predictors of sarcopenia.”

    Humanselderly diabetic patientsserumn = 80

    Association of adiponectin and nutritional indices with sarcopenia in elderly diabetic patients

    Journal of basic and clinical physiology and pharmacology

  6. Sarcopenia is associated with adiponectin in humans (low muscle mass).

    “Older women with low muscle mass showed higher plasma levels of adiponectin, sTNFr1, and IL-8 compared to the regular muscle mass group.”

    Humanslow muscle massplasmafemalesn = 71

    Adiponectin Is a Contributing Factor of Low Appendicular Lean Mass in Older Community-Dwelling Women: A Cross-Sectional Study

    Journal of clinical medicine

  7. Adiponectin is associated with sarcopenia in patients with cardiovascular diseases (significantly higher in sarcopenic than non-sarcopenic patients).

    “Serum concentrations of adiponectin and sialic acid were significantly higher in sarcopenic than non-sarcopenic CVD patients.”

    Humansin patients with cardiovascular diseases

    New diagnostic index for sarcopenia in patients with cardiovascular diseases

    PloS one

  8. Adiponectin is associated with sarcopenia in humans.

    “Sarcopenic patients had lower levels of hemoglobin, albumin, total protein, calcium, triglycerides, uric acid and adiponectin (p < 0.05).”

    Humans

    Serum markers of inflammation and oxidative stress in sarcopenia

    Aging clinical and experimental research

More on Sarcopenia

Frailty

upin humans2downin dogs1downin humans1

4 studies
  1. Frailty is associated with adiponectin in patients with stable CAD (AUC=0,766; 95% confidence interval: 0,643-0,889, p=0,013).

    “Binary logistic regression confirmed a significant association between the frailty according to the "Age is not a barrier" questionnaire and lower serum adiponectin levels in patients with stable CAD”

    Humansin patients with stable CADn = 174

    Association of frailty with adipokine levels in patients with stable coronary artery disease

    CARDIOVASCULAR THERAPY AND PREVENTION

  2. Adiponectin is associated with frailty in humans.

    “Frail older adults showed higher levels of BUN, IL-6, adiponectin, vaspin, and glucose and lower levels of IGF-1, HDL, and HGB compared with nonfrail participants.”

    Humans

    Elevated serum IL-6 and adiponectin levels are associated with frailty and physical function in Chinese older adults

    Clinical interventions in aging

  3. Adiponectin is associated with frailty in humans (Japanese older adults in the general population).

    “higher plasma adiponectin levels were associated with frailty status in older Japanese adults in the general population.”

    HumansJapanese older adults in the general population51.8% mensn = 353

    High plasma adiponectin levels are associated with frailty in a general old-old population: The Septuagenarians, Octogenarians, Nonagenarians Investigation with Centenarians study

    Geriatrics & gerontology international

  4. Adiponectin is associated with frailty in dogs.

    “higher levels of glucose and adiponectin were correlated with reduced frailty scores”

    Animals

    Changes in insulin, adiponectin and lipid concentrations with age are associated with frailty and reduced quality of life in dogs

    Scientific reports

Cognitive function

mixedin humans1upin humans1downin humans1

3 studies
  1. Adiponectin is associated with cognitive function in humans (obesity) (p = 0.731; r < 0.01 (as reported; statistical significance is inconsistently reported)).

    “this study found that adiponectin levels were associated with cognitive function in the obese elderly population examined.”

    Humansobesity

    Relationship Between Adiponectin Levels and Cognitive Function in Elderly Patients with Obesity in RSUD Dr. Mohamad Soewandhie Surabaya

    International Journal Of Health Science

  2. Adiponectin is associated with cognitive function in humans (elderly diabetic patients with MCI and depressive symptoms).

    “adiponectin concentration was negatively correlated with hs-CRP, TNF-α, HbA1c, and GDS-30 scores and positively correlated with MoCA scores”

    Humanselderly diabetic patients with MCI and depressive symptomsn = 178

    Adiponectin and Inflammatory Marker Levels in the Elderly Patients with Diabetes, Mild Cognitive Impairment and Depressive Symptoms

    International journal of molecular sciences

  3. Adiponectin is associated with cognitive function in humans (B = -0.459; 95% CI -0.915, -0.002).

    “poorer performance in language (B = -0.676; 95% CI -1.23, -0.121), and global cognition (B = -0.459; 95% CI -0.915, -0.002)”

    Humansplasmafemalesn = 535

    Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging

    Journal of Alzheimer's disease : JAD

Obesity

downin humans3OR 0.47

3 studies
  1. Adiponectin is linked with a lower risk of obesity in humans (OR 0.47, 95% CI 0.24-0.93).

    “adiponectin levels showed inverse associations with obesity (OR 0.47, 95% CI 0.24-0.93)”

    Humans

    Cross-Sectional and Longitudinal Associations of Irisin and Adiponectin With Obesity, Sarcopenia and Sarcopenic Obesity

    Journal of cachexia, sarcopenia and muscle

  2. Obesity is associated with adiponectin in humans (obesity).

    “along with lower levels of adiponectin and PPAR-γ”

    Humansobesityserumfemalesn = 156

    Biomarkers of Oxidative Stress, Inflammation, and Brain Damage in Mexican Women over 60 Years of Age with Obesity

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

  3. Obesity is associated with adiponectin in persons with obesity compared to normal weight (p = 0.007).

    “Adiponectin levels were significantly lower in persons with obesity than in those with normal weight (p = 0.007).”

    Reviewin persons with obesity compared to normal weight

    Recent Insights Into Circulating Adipokines in Obesity: Systematic Review and Meta-Analysis

    Obesity science & practice

More on Obesity

Type 2 diabetes

downin humans3OR 0.31–0.766

3 studies
  1. Adiponectin is linked with a lower risk of type 2 diabetes in humans (adjusted for covariates; p=0.03 for interaction by gender) (OR: 0.31; 95% CI: 0.19-0.72).

    “lower odds of diabetes in women (OR: 0.31; 95% CI: 0.19-0.72; p=0.03 for interaction by gender)”

    Humansadjusted for covariates; p=0.03 for interaction by genderfemalesn = 891

    Adiponectin and Adiponectin/Leptin Ratio Associate with Cardiometabolic Risk in South Asian Americans: Updates from the MASALA Study

    AHA Scientific Sessions 2025 abstract

  2. Adiponectin is linked with a lower risk of type 2 diabetes in offspring.

    “fasting serum HDL-C, adiponectin, and sex hormone binding globulin were protective against incident T2D among the offspring (all P<0.05).”

    Humansin offspring

    Low Risk for Developing Diabetes Among the Offspring of Individuals With Exceptional Longevity and Their Spouses

    Frontiers in clinical diabetes and healthcare

  3. Adiponectin is linked with a lower risk of type 2 diabetes in humans (OR 0.766 per 0.1 log microg/ml, P = 0.029).

    “serum adiponectin level (odds ratio [per 0.1 log microg/ml] 0.766, P = 0.029) was an independent risk factor for the progression to type 2 diabetes.”

    Humans5 years

    Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study

    Diabetes care

More on Type 2 diabetes

Cardiovascular mortality

upin humans3HR 1.67–4.78

3 studies
  1. Adiponectin predicts cardiovascular mortality in humans (CKD patients undergoing hemodialysis) (HR 4.78 (95% CI 2.26-10.13)).

    “Higher ADPN levels were predictors of all-cause mortality (hazard ratio (HR) [95% CI] 2.17 [1.41-3.33]), CVD mortality (HR 4.78 [2.26-10.13])”

    HumansCKD patients undergoing hemodialysis5-year follow-upn = 518

    Higher Serum Adiponectin Levels Predict Poorer Outcomes in Patients Undergoing Hemodialysis

    ADA Scientific Sessions 2025 abstract

  2. Adiponectin is linked with a higher risk of cardiovascular mortality in humans (HR: 1.67 [95% CI: 1.19-2.32]).

    “and CVD death (HR: 1.67 [95% CI: 1.19-2.32])”

    Humans

    Does Adiponectin Inform Cardiovascular Risk in Older Adults?: The ARIC Study

    JACC. Advances

  3. Adiponectin is associated with cardiovascular mortality in humans (Without baseline cardiovascular disease; highest versus lowest adiponectin quartile) (Q4 versus Q1: HR 2.43, 95% CI 1.15–5.15).

    “CVD mortality Q4 versus Q1 (HR = 2.43; 95% CI 1.15, 5.15)”

    HumansWithout baseline cardiovascular disease; highest versus lowest adiponectin quartileMedian 10.4 years44% womensn = 3,263

    Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study)

    The American journal of cardiology

Mortality

upin humans3HR 2.17–4.155

3 studies
  1. Adiponectin predicts mortality in humans (CKD patients undergoing hemodialysis) (HR 2.17 (95% CI 1.41-3.33)).

    “Higher ADPN levels were predictors of all-cause mortality (hazard ratio (HR) [95% CI] 2.17 [1.41-3.33])”

    HumansCKD patients undergoing hemodialysis5-year follow-upn = 518

    Higher Serum Adiponectin Levels Predict Poorer Outcomes in Patients Undergoing Hemodialysis

    ADA Scientific Sessions 2025 abstract

  2. Adiponectin predicts mortality in humans (patients undergoing transcatheter aortic valve implantation) (HR 4.155 (95% CI: 1.364-12.655), p = .004).

    “Compared with patients with the lowest adiponectin level, patients in the third tertile had a hazards ratio of all-cause mortality after TAVI of 4.155 (95% CI: 1.364-12.655) (p = .004).”

    Humanspatients undergoing transcatheter aortic valve implantationserummean 1779 daysn = 77

    Adiponectin serum level is an independent and incremental predictor of all-cause mortality after transcatheter aortic valve replacement

    Clinical cardiology

  3. Adiponectin is associated with mortality in humans (Without baseline cardiovascular disease; highest versus lowest adiponectin quartile) (Q4 versus Q1: HR 2.27, 95% CI 1.47–3.50).

    “increasing adiponectin quartiles were positively associated with all-cause mortality Q4 versus Q1 (hazard ratio [HR] = 2.27; 95% confidence interval [CI] 1.47, 3.50)”

    HumansWithout baseline cardiovascular disease; highest versus lowest adiponectin quartileMedian 10.4 years44% womensn = 3,263

    Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study)

    The American journal of cardiology

Muscle mass

downin humans2

2 studies
  1. Adiponectin is associated with muscle mass in humans (maintenance hemodialysis outpatients).

    “Adiponectin showed significant inverse correlations with BMI, muscle mass, and fat mass.”

    Humansmaintenance hemodialysis outpatientsn = 23

    Serum Myonectin Levels Are Positively Associated With Physical Function and Lower Frailty-Related Limitation in Maintenance Hemodialysis Patients: A Cross-Sectional Study

    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

  2. Adiponectin is associated with muscle mass in humans (r = -0.296; p = 0.001).

    “plasma adiponectin levels negatively correlated with BMI (r = -0.129; p = 0.03), lean mass (r = -0.252; p = 0.001), muscle mass (r = -0.296; p = 0.001)”

    Humansskeletal musclen = 393

    Age-related adiponectin resistance in human skeletal muscle dysfunction: in vivo and in vitro evidence

    Journal of translational medicine

Triglyceride

downin humans2

2 studies
  1. Adiponectin is associated with triglyceride in humans after 3 months of exercise cessation.

    “negatively correlated with triglyceride levels after exercise cessation”

    Human trialafter 3 months of exercise cessation3 monthsn = 49

    Exercise cessation in active older adults: Effects on inflammatory markers and adiponectin

    Geriatrics & gerontology international

  2. Adiponectin is associated with triglyceride in young MASLD patients (r = -0.95, p < 0.001).

    “Strong inverse correlation was found between the adiponectin and total lactate dehydrogenase activity (r = -0.81, p < 0.05), GGT (r = -0.93, p = 0.008) and the triacylglycerols content (r = -0.95, p < 0.001) in the blood in young patients.”

    Humansin young MASLD patients

    Association of Pro- and Anti-Inflammatory Cytokines and Adipokines with Liver Function Parameters and Lipid Profile in Metabolic Dysfunctional-Associated Steatotic Liver Disease Patients of Different Age

    Lviv clinical bulletin

More on Triglyceride

Physical function

downin humans2

2 studies
  1. Adiponectin is associated with physical function in humans (r = -0.163; p = 0.007).

    “and physical performance (SPPB score; r = -0.163; p = 0.007)”

    Humansn = 393

    Age-related adiponectin resistance in human skeletal muscle dysfunction: in vivo and in vitro evidence

    Journal of translational medicine

  2. Adiponectin is associated with physical function in humans after adjustment for age and sex (r=-0.195, P=0.029).

    “the only markers correlated with physical function were IL-6 (r=-0.180, P=0.044) and adiponectin (r=-0.195, P=0.029)”

    Humansafter adjustment for age and sex

    Elevated serum IL-6 and adiponectin levels are associated with frailty and physical function in Chinese older adults

    Clinical interventions in aging

ADIPOQ

upin humans2

2 studies
  1. ADIPOQ is associated with adiponectin in humans (GG genotype of rs1501299, after both hypocaloric diets) (Diet P: 9.3±3.0 ng/dl vs. Diet M: 8.2±2.9 ng/dl: p=0.38).

    “Only subjects with GG genotype showed a significant increase of the adiponectin levels after both diets”

    Human trialGG genotype of rs1501299, after both hypocaloric diets12 weeks

    Single nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 interact with different type of dietary fatty acids in two hypocaloric diets

    European review for medical and pharmacological sciences

  2. ADIPOQ is associated with adiponectin in humans.

    “The -11391 A-allele was associated with a higher serum adiponectin concentration at baseline (n = 290; P < 0.001).”

    Human trialn = 290

    Adiponectin gene variant interacts with fish oil supplementation to influence serum adiponectin in older individuals

    The Journal of nutrition

More on ADIPOQ

MANF

downin humans1downin mice1

1 study
  1. MANF is associated with adiponectin in humans.

    “Plasma MANF levels correlated inversely with adiponectin”

    Human trialn = 40

    Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Upregulated with Therapeutic Fasting in Humans and Diet Fat Withdrawal in Obese Mice

    Scientific reports

  2. MANF is associated with adiponectin in mice.

    “Liver MANF and serum adiponectin concentrations correlated inversely in mice”

    Animalsliver

    Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Upregulated with Therapeutic Fasting in Humans and Diet Fat Withdrawal in Obese Mice

    Scientific reports

More on MANF

Skeletal muscle mass

upin humans1

1 study
  1. Adiponectin is associated with skeletal muscle mass in normal-weight older women.

    “higher baseline adiponectin concentrations were associated with greater muscle mass gains after 12 weeks of RT (p = 0.020”

    Human trialin normal-weight older women12 weeksn = 14

    Effects of 12-Week Resistance Training on Metabolic and Immune Responses in Normal-Weight and Older Women with Obesity

    International journal of molecular sciences

Change in relative VO2max

upin humans1

1 study
  1. Change in relative VO2max is associated with adiponectin in humans (correlation of changes over the 12-week intervention) (r = 0.427).

    “while relative VO2max changes correlated positively with adiponectin (r = 0.427, P < 0.05)”

    Human trialcorrelation of changes over the 12-week interventionplasma-serum12 weeksfemales

    Concurrent improvement of cardiorespiratory fitness and modulation of inflammatory markers via 12-week high-intensity interval nordic walking in postmenopausal women with overweight or obesity: a quasi-experimental study

    BMC sports science, medicine & rehabilitation

Lean mass

downin humans1

1 study
  1. Adiponectin is associated with lean mass in humans (-5.0% (95% CI: -9.4%, -2.4%)).

    “Lean mass declined by 5.0% (95% CI: -9.4%, -2.4%) in the adjusted model and by 13.4% (95% CI: -17.4%, -9.3%) in the unadjusted model.”

    Human trialper twofold increase in adiponectin over 36 months, after adjusting for procedure, age, and sex3 years (surgical groups) or 2 years (Diet group)n = 55

    Long-term body composition changes after bariatric surgery and their association with fat- and bone-derived hormones

    Endocrine

More on Lean mass

All 121

Funding

12 grants since 2016

National Institute of Neurological Disorders and Stroke$1.9MNational Heart, Lung, and Blood Institute$1.8MUS Department of Veterans Affairs

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 12Jan 2026: 27Feb 2026: 34Mar 2026: 19Apr 2026: 12May 2026: 8Jun 2026: 17Jul 2026: 12Aug 2026: 11Sep 2026: 17Oct 2026: 18Nov 2026: 19206 papers in 12 months
European Review of Aging and Physical Activity

Low-intensity exercise improved fitness in women 85 and older

Handgrip strength was an estimated 3.71 kilograms higher with resistance training than in controls after 24 weeks; both exercise programs improved other fitness tests.Handgrip strength was an estimated 3.71 kilograms higher with resistance training than in controls after 24 weeks; both exercise programs improved other fitness tests.

Randomized trial · 90 peopleResistance training
Nutrients

Walnuts had little effect on body fat and weight in older adults

In a two-year randomized controlled trial of 326 healthy older adults, daily walnuts had little effect on body composition compared with avoiding walnuts.In a two-year randomized controlled trial of 326 healthy older adults, daily walnuts had little effect on body composition compared with avoiding walnuts.

Randomized trial · 326 peopleInterventions

See all 901 papers on adiponectin